glycopyrrolate has been researched along with Cholera Infantum in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferguson, GT; Goodin, T; Kerwin, E; Tosiello, R; Wheeler, A | 1 |
| ORCHOW, HS | 1 |
| Akdamar, K; Ertan, A; McMahon, FG; Ryan, JR | 1 |
| Domino, EF; Kothary, SP; Pandit, SK; Pandit, UA; Samra, SK | 1 |
| Blackshear, JL; Bozymski, EM; Sinar, DR | 1 |
3 trial(s) available for glycopyrrolate and Cholera Infantum
| Article | Year |
|---|---|
Long-term safety of glycopyrrolate/eFlow
Topics: Administration, Inhalation; Aged; Bronchodilator Agents; Cough; Female; Forced Expiratory Volume; Gastrointestinal Diseases; Glycopyrrolate; Headache; Humans; Male; Middle Aged; Muscarinic Antagonists; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Severity of Illness Index; Tiotropium Bromide; Vital Capacity | 2017 |
Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial.
Topics: Acute Disease; Adult; Clinical Trials as Topic; Delayed-Action Preparations; Drug Synergism; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Glycopyrrolate; Humans; Intestinal Mucosa; Male; Peptic Ulcer; Peptic Ulcer Perforation; Potassium Chloride | 1982 |
Effects of oral potassium supplements on upper gastrointestinal mucosa: multicenter clinical comparison of three formulations and placebo.
Topics: Administration, Oral; Adolescent; Adult; Drug Compounding; Edema; Gastrointestinal Diseases; Gastroscopy; Glycopyrrolate; Humans; Hyperemia; Male; Mucous Membrane; Potassium Chloride; Random Allocation; Stomach Ulcer | 1986 |
2 other study(ies) available for glycopyrrolate and Cholera Infantum
| Article | Year |
|---|---|
Management of gastrointestinal disorders with glycopyrrolate in general practice.
Topics: Disease Management; Family Practice; Gastroenterology; Gastrointestinal Diseases; General Practice; Glycopyrrolate; Parasympatholytics | 1962 |
Physostigmine fails to reverse clinical, psychomotor, or EEG effects of lorazepam.
Topics: Adult; Anti-Anxiety Agents; Brain; Cardiovascular Diseases; Double-Blind Method; Electroencephalography; Female; Gastrointestinal Diseases; Glycopyrrolate; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Physostigmine; Psychomotor Performance | 1983 |